Searched over 200M research papers
10 papers analyzed
These studies suggest that hypertensive cardiovascular disease is a significant cause of death due to its association with increased risk of sudden cardiac death, structural and functional cardiac changes, and high blood pressure-related complications.
20 papers analyzed
Hypertension is a leading cause of cardiovascular disease (CVD) and premature death globally. It is responsible for more cardiovascular deaths than any other modifiable risk factor, surpassing even cigarette smoking in some regions . Elevated blood pressure (BP) is directly linked to an increased risk of sudden cardiac death (SCD), heart failure, and other cardiovascular complications .
The prevalence of hypertension is rising, particularly in low- and middle-income countries (LMICs), where awareness, treatment, and control of hypertension are notably low. Approximately 31.1% of adults worldwide had hypertension in 2010, with higher rates observed in LMICs compared to high-income countries. This widespread prevalence contributes significantly to the global burden of cardiovascular mortality.
Hypertension is a significant risk factor for sudden cardiac death (SCD), accounting for over 60% of all cardiovascular deaths. Studies have shown that individuals with hypertension have a more than twofold increased risk of SCD compared to those with normal BP . The presence of left ventricular hypertrophy (LVH), a common consequence of prolonged hypertension, further elevates the risk of SCD due to associated arrhythmias and myocardial ischemia .
Hypertensive heart disease encompasses a range of cardiac abnormalities, including LVH, left atrial enlargement, and diastolic dysfunction, all of which contribute to increased cardiovascular mortality . The structural and functional changes in the heart due to hypertension lead to significant arrhythmias, such as atrial fibrillation (AF) and ventricular arrhythmias, which are major predictors of SCD .
The economic impact of hypertension is substantial, particularly in LMICs where healthcare resources are limited. The financial burden includes costs related to the management of hypertension and its complications, such as heart failure and stroke. Comprehensive strategies for hypertension prevention and control are essential to mitigate these costs and reduce the overall burden of cardiovascular disease.
Hypertension remains a critical public health issue due to its significant role in cardiovascular mortality, particularly sudden cardiac death. Effective management and control of hypertension, along with lifestyle modifications, are crucial in reducing the risk of cardiovascular events and improving global health outcomes. Addressing the disparities in hypertension awareness and treatment, especially in LMICs, is vital for reducing the global burden of hypertensive cardiovascular disease.
Most relevant research papers on this topic